Study: TNF inhibitors improve extraintestinal IBD manifestations
SAN DIEGO – Tumor necrosis factor inhibitors improved the extraintestinal manifestations of inflammatory bowel disease (IBD) among more than half of affected patients, according to a national cohort study.
“The best response rates were for psoriasis, aphthous stomatitis, uveitis, and peripheral...
Source: Skin and Allergy News - Category: Dermatology Source Type: news
More News: Allergy | Allergy & Immunology | Dermatology | Inflammatory Bowel Disease | Psoriasis | Skin | Study